Compare · KIDS vs MDLN
KIDS vs MDLN
Side-by-side comparison of OrthoPediatrics Corp. (KIDS) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KIDS and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $51.52B, about 62.6x KIDS ($822.5M).
- MDLN has been more active in the news (13 items in the past 4 weeks vs 7 for KIDS).
- MDLN has more recent analyst coverage (25 ratings vs 8 for KIDS).
- Company
- OrthoPediatrics Corp.
- Medline Inc.
- Price
- -
- -
- Market cap
- $822.5M
- $51.52B
- 1M return
- -
- +8.89%
- 1Y return
- -
- -3.93%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2025
- News (4w)
- 7
- 13
- Recent ratings
- 8
- 25
OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Latest KIDS
- OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
- OrthoPediatrics to Participate in Upcoming Conferences
- SEC Form 10-Q filed by OrthoPediatrics Corp.
- SEC Form 8-K filed by OrthoPediatrics Corp.
- SEC Form 8-K filed by OrthoPediatrics Corp.
- OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
- OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
- PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy Month
- OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026
- OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX
Latest MDLN
- Chief Legal Officer Liberman Alexander M. was granted 798,680 units of Class B Common Stock, increasing direct ownership by 352% to 1,025,603 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. was granted 520,127 units of Class B Common Stock, increasing direct ownership by 207% to 771,197 units (SEC Form 4)
- Chief Commercial Officer Golwas Douglas P was granted 895,512 units of Class B Common Stock, increasing direct ownership by 164% to 967,560 units (SEC Form 4)
- Chief Executive Officer Boyle James M was granted 2,516,260 units of Class B Common Stock, increasing direct ownership by 7,591% to 1,869,921 units (SEC Form 4)
- Medline Inc. announces launch of secondary offering of Class A common stock
- SEC Form S-1 filed by Medline Inc.
- SEC Form SCHEDULE 13G filed by Medline Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
- Medline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits